CrushSCI.com
Journal Selection & Manuscript Polishing Services
MODERN PATHOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

MODERN PATHOLOGY

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
141.9Average days
140Median days
40Fastest days
257Longest days
2432025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

133 days

Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations With Race and Prostate Cancer Outcomes

AuthorsKaren S. Sfanos; Rebecca Morton; Julia N. Flores; Rebecca Y. Sosa; Sarah E. Ernst; Luke Mummert; Jessica Hicks; Tamara L. Lotan; Jiayun Lu; Yuezhou Jing; James R. Eshleman; Corrine E. Joshu; Angelo M. De Marzo

AffiliationsDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Source PDF DOI Publisher page
117 days

Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin

AuthorsShira Ronen; Alexandra Meurgey; Michael Michal; Daniel Pissaloux; Franck Tirode; Colleen J. Beatty; Nicolas Macagno; Gonzague de Pinieux; David S. Cassarino; Nicolas Ortonne; Laurence Lamant; Eduardo Calonje; Michael Tetzlaff; Philip E. LeBoit; Steven D. Billings; Thibault Kervarrec

AffiliationsDepartment of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio; Department of Biopathology, Center Léon Bérard, Lyon, France; Bioptická Laboratoř, Pilsen, Czech Republic; Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic; Department of Dermatology and Pathology, West Virginia University, Morgantown, West Virginia; Department of Pathology, Aix Marseille University, INSERM, APHM MMG, UMR1251, La Timone Hospital, Marseille, France; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; Department of Pathology and Dermatopathology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California; Department of Pathology, Assistance Publique—Hopitaux de Paris (AP-HP), Henri Mondor Hospital, Créteil, France; Paris est Créteil University (UPEC), INSERM U955 (Team Ortonne), Créteil, France; Department of Pathology, Oncopole, Toulouse, France; Department of Dermatopathology, St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Trust, London, United Kingdom; Department of Pathology and Dermatology (Dermatopathology and Oral Pathology Service), University of California, San Francisco, California

Source PDF DOI Publisher page
147 days

An Immunohistochemistry-based Decision Flowchart to De-escalate Axillary Surgery for Biopsy-Diagnosed Pure Ductal Carcinoma In Situ (DCIS) of the Breast

AuthorsJulia A.M. Riggi; Christine Galant; Caroline Bouzin; Aurélie Daumerie; Naïma Benhaddi; Hilde Vernaeve; Nathanael Dubois; Maud Vassilieff; Mirela Roman; Latifa Fellah; Amandine Gerday; Carolien H.M. van Deurzen; Martine Berlière; Mieke R. Van Bockstal

AffiliationsDepartment of Pathology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Université catholique de Louvain (UCLouvain), Institut de Recherche Expérimentale et Clinique (IREC), Morphology Department (MORF), Brussels, Belgium; Université catholique de Louvain (UCLouvain), Institut de Recherche Expérimentale et Clinique (IREC) 2IP Platform (Imaging Department) (RRID: SCR_023378), Brussels, Belgium; Department of Gynecology, Breast Clinic, Clinique Saint-Jean, Brussels, Belgium; Department of Gynecology, Breast Clinic Isala, Centre Hospitalier et Universitaire (CHU) Saint-Pierre, Brussels, Belgium; Department of Gynecology, Breast Clinic, Institut Roi Albert II (IRAII), Cliniques Universitaires Saint-Luc, Brussels, Belgium; Department of Pathology, Erasmus Medical Center (EMC), Rotterdam, the Netherlands; Université catholique de Louvain, Institut de Recherche Expérimentale et Clinique (IREC), Gynecology Research Unit, Brussels, Belgium

Source PDF DOI Publisher page
40 days

Lung Carcinoids with Sustentacular Cells and Low Keratin Expression: A Common yet Underrecognized Phenomenon with Diagnostic and Biological Implications

AuthorsJonathan Willner; Rania G. Aly; Prithviraj Solanki; Irfan Khan; Christina E. Wilson; Francis Bodd; Irina Linkov; Olca Basturk; Laura H. Tang; Amitabh Srivastava; Anuradha Gopalan; Jason Chang; Marina K. Baine; William D. Travis; Jake June-Koo Lee; Charles M. Rudin; Natasha Rekhtman

AffiliationsDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, Tan Tock Seng Hospital, Singapore; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

Source PDF DOI Publisher page
257 days

RUNX2 Rearrangement as a Recurrent Molecular Event and Diagnostic Marker in Salivary Gland Keratocystoma

AuthorsMin Wang; Jia-Jun Qian; Nan-Nan Leng; Rui Yin; Yi-Ning He; Chun-Ye Zhang; Ting Gu; Jun-Qing Xue; Zhen Tian; Jiang Li; Li-Zhen Wang; Rong-Hui Xia

AffiliationsDepartment of Oral Pathology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China; Biostatistics Office of Clinical Research Unit, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Source PDF DOI Publisher page
112 days

Clinicopathological, Molecular, and DNA Methylation Analysis of Ossifying Fibromyxoid Tumors Delineates the ZC3H7B::BCOR Subset as a Distinct Entity

AuthorsNatálie Klubíčková; Josephine K. Dermawan; Baptiste Ameline; Petr Martínek; Tomáš Vaněček; Veronika Hájková; Nikola Ptáková; Petr Grossmann; Petr Šteiner; Stanislav Kormunda; Raul E. Perret; François Le Loarer; Carina A. Dehner; Jorge Torres-Mora; John M. Gross; John S.A. Chrisinger; Gregory Charville; Kemal Kösemehmetoĝlu; Sintawat Wangsiricharoen; Jeanne Meis; Zuzana Špůrková; Michal Zámečník; Iva Staniczková Zambo; Tomáš Klinger; Marián Švajdler; Zdeněk Kinkor; Květoslava Michalová; Daniel Baumhoer; Michal Michal; Cristina R. Antonescu; Michael Michal

AffiliationsDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, Prague, Czech Republic; Bioptická Laboratory Ltd., Plzen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic; Soft Tissue and Bone Pathology Section, Department of Pathology, Cleveland Clinic, Cleveland, Ohio; Bone Tumor Reference Center, Institute for Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri; Department of Pathology, Stanford University Hospital, Stanford, California; Department of Pathology, Hacettepe University, Ankara, Turkey; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, Oregano; Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, Bulovka University Hospital, Prague, Czech Republic; Department of Histopathology, Medicyt Trencin, Trencin, Slovakia; Department of Pathological Anatomy, Medical Faculty, Masaryk University and St. Anne’s University Hospital, Brno, Czech Republic; Department of Pathology – Centrum PATOS, Regional Hospital Liberec, Liberec, Czech Republic; Institute of Pathology, HOCH Health Ostschweiz, St Gallen, Switzerland; Basel Research Centre for Child Health, University of Basel and ETH Zurich, Basel, Switzerland; Department of Histopathology, Cytopathos, Ltd., Bratislava, Slovakia; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

Source PDF DOI Publisher page
177 days

Pulmonary Neuroendocrine Tumor Artificial Intelligence–Assisted Prediction of Postoperative Recurrence From Tumor Biopsy Specimens

AuthorsFarhan Akram; Teodora E. Trandafir; Tijmen J.J. van Weert; Tiina Vesterinen; Laura Moonen; Lisa M. Hillen; Michael A. den Bakker; Frank W.J. Heijboer; Ronald A.M. Damhuis; Andrew P. Stubbs; Ernst-Jan M. Speel; Yunlei Li; Anne-Marie C. Dingemans; Jules Derks; Jan H. von der Thüsen

AffiliationsDepartment of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Pathology, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands; HUS Diagnostic Center, Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands; Department of Respiratory Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands; GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands

Source PDF DOI Publisher page
121 days

Immune-Related Pathological Features and Predictive Score in Intrahepatic Cholangiocarcinoma Treated With Combined Conversion Immunotherapy

AuthorsWanwan Chen; Yimeng Sang; Gwyneth Shook Ting Soon; Edwin Jun Chen Chew; Gaohua Wu; Xiyi Lin; Rongkui Luo; Qiang Gao; Jian Zhou; Hongping Xia; Kai Zhu; Ruoyu Shi

AffiliationsDepartment of Pathology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China; Wenzhou Key Laboratory of Integrated Traditional Chinese and Western Medicine Treatment for Gastrointestinal Diseases, Wenzhou, China; Zhongda Hospital & Cancer Institute of Xuzhou Central Hospital & Jiangsu Provincial Key Laboratory of Critical Care Medicine & Institute for Advanced Study of Life and Health, School of Medicine, Southeast University, Nanjing, China; Department of Pathology, National University Hospital, National University Health System, Singapore; Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital, Singapore; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China; The 4th Class of Clinical Medicine, 2022 Batch, Second Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Pathology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China

Source PDF DOI Publisher page
147 days

Artificial Intelligence-informed Architectural Insights of 3-dimensional Glandular Networks Identify Patients With Prostate Cancer at a Higher Risk of Biochemical Recurrence

AuthorsJennifer Salguero-Lopez; Sebastian Medina; Robert Serafin; Rui Wang; Hisham Abdeltawab; Sandeep Manandhar; Pushkar Mutha; Rohan Dhamdhere; Suet Chow; Kevin W. Bishop; Reba E. Daniel; Naoto Tokuyama; Tilak Pathak; Lawrence D. True; Germán Corredor; Eduardo Romero; Priti Lal; Jonathan T.C. Liu; Anant Madabhushi

AffiliationsWallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia; Department of Electrical and Electronic Engineering, Universidad Nacional de Colombia, Bogotá, Colombia; Department of Mechanical Engineering, University of Washington, Seattle, Washington; Department of Systems and Biomedical Engineering, Cairo University, Giza, Egypt; Department of Bioengineering, University of Washington, Seattle, Washington; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Laboratory Medicine & Pathology, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Laboratory Medicine & Pathology, University of Washington School of Medicine, Seattle, Washington; Atlanta Veterans Affairs Medical Center, Decatur, Georgia; Department of Telemedicine, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia; Department of Pathology, Stanford University School of Medicine, Stanford, California

Source PDF DOI Publisher page
168 days

Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group

AuthorsQiudan Shen; Xiaoyan Huang; Xiaoqiong Wang; Wen Shuai; Hong Fang; Ellias Jabbour; Weina Chen; Mehrnoosh Tashakori; Mahsa Khanlari; Xiaojun Wu; Lina Shao; Ling Zhang; Siba El Hussein; Sergej Konoplev; Joseph D. Khoury; Guilin Tang; Wei Wang; Sa A. Wang; L. Jeffrey Medeiros; Shimin Hu

AffiliationsDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, New York University Langone Health, New York, New York; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York; Department of Pathology & Laboratory Medicine Miller School of Medicine, University of Miami, Miami, Florida; Department of Pathology, Duke University School of Medicine, Durham, North Carolina; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota; Department of Pathology and Laboratory Medicine, St. Jude Children’s Research Hospital, Memphis, Tennessee; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Pathology, The University of Michigan Medical School, Ann Arbor, Michigan; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; Department of Pathology and Laboratory Medicine, The University of Vermont College of Medicine, Burlington, Vermont; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, University of Nebraska Medical Center, Omaha, Nebraska

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.